ABSTRACT
Introduction
The use of nerve stimulation for treating and controlling a variety of medical, psychiatric, and neurological disorders has seen significant growth over the last several decades. In particular, vagal nerve stimulation (VNS) has been the subject of considerable research. (1) (2) (3) Currently VNS has numerous potential clinical applications from heart failure to endocrine regulation. The vagus nerve extensively innervates the thoracic and abdominal viscera (afferent 80% of fibers) and is an important route of information into the central nervous system (efferent 20% of fibers). (4) Activation of the parasympathetic pathway leads to negative chronotropic, dromotropic, and inotropic changes of the heart function. (5, 6) The vagus nerve is composed of different fiber types. (7) The ability to selectively stimulate certain superficial compartments of peripheral nerves has been demonstrated by several authors. (8) (9) (10) (11) We have previously reported that selective VNS in humans is possible. (12) However, detailed human data on selective biphasic VNS and its effects on heart rate and systemic arterial pressure are not available. The aim of the present study was to find a clinically acceptable selective biphasic VNS at different stimulation frequencies, which could allow gradual regulation of heart rate and systemic arterial pressure.
Methods
Two patients undergoing carotid endarterectomy and coronary by-pass surgery were included in the study. The study was approved by The National Medical Ethics Committee, Ministry of Health, Republic of Slovenia (No. 142/02/07, 13 February 2007). Before any trial activity was performed, Informed Consent in accordance with the Informed Consent Procedure was properly obtained. Anesthesia One hour before surgery, patients were premedicated orally with diazepam 5 mg (Apaurin, Krka, Slovenia) and pantoprazole 40 mg (Controloc, Altana Pharma AG, Germany). For induction into anesthesia, the short-acting intravenous anesthetic agent propofol (Propofol 1% Fresenius, Fresenius Kabi, Austria) was used in doses 1 -2 mg/kg of body weight (BW) administered as slow bolus doses (20 -30 s), while remifentanyl (Ultiva, GlaxoSmithKline, UK), as a short-acting synthetic -opioid agonist, was used in an initial loading dose of 1 -1.5 g/kg of BW administered in a 30 to 60 s period. To facilitate endotracheal intubation a dose of 80 to 100 Pg/kg of BW of the muscle relaxant vecuronium bromide (Norcuron, Organon, Oss, Holland) was administered intravenously. For maintenance of general anesthesia an inhalation anesthetic isoflurane (Forane, Abbott Laboratories, Queenborough, UK) was used in inspired concentrations of 1.5 to 3.0 %, and analgesia was assured by a continuous infusion of 0.3 -0.5 g/kg/min of remifentanyl. Vecuronium bromide was administered if muscle relaxation of a higher degree was needed for any reason. Low-flow anesthetic technique was performed by administering continuously inhaled fresh gas, flow up to 1.5 L/min of oxy- Hemodynamic monitoring Pressure at airway opening was monitored using a transducer for invasive blood pressure monitoring (DPT-6000, PvB-Critical care, Smiths Medical Deutschland GmbH, Germany) and attached to a cuffed endotracheal tube. Invasive systemic arterial pressure was measured by the same transducers attached to an intra-arterial line placed in the left radial artery. The Swan-Ganz catheter (Swan-Ganz CCOmbo Pulmonary Artery Catheter and Vigilance II Monitor, Edwards Inc., USA) for continuous cardiac output, pulmonary artery pressure and central venous pressure measurements was inserted after induction into general anesthesia via the right jugular internal vein. Design and implantation of a multielectrode spiral cuff The self-sizing spiral design was chosen for the cuff. A detailed description of the 39-electrode cuff, having thirteen circumferential groups of three electrodes (GTE 1-13) and fabrication can be found in our previous report. (14) The cuff is 18 mm in length and 2.5 mm in diameter (inner diameter of the first layer) and has 2.25-2.75 turns, snugly fitting the nerve in its resting position.
Cuff implantation
After left internal carotid endarterectomy and off-pump coronary artery by-pass surgery the cuff was implanted around the left vagus nerve. The vagus nerve was identified in the carotid sheath in a posterior groove between the carotid artery and the jugular vein. Vessel loops were used to mobilize the vagus nerve so that about 2.5 to 3 cm were available for attachment of the spiral cuff. Afterwards, the nerve segment was completely freed from its surrounding tissues and the cuff was then carefully attached to the exposed nerve. Since the need to "seal" the cuff on the nerve with a suture was unnecessary, cuff implantation was a relatively simple operation. Namely, the self-fitting nature of the spiral design makes it easy to snuggly place the cuff on the nerve. The spiral cuff design was devised so as to induce very low pressures when installed on a nerve, thus eliminating any passively-induced nerve damage. Special care was taken to route the leads to the connector in order to avoid mechanical tension being transmitted to the cuff. Further precautions were taken during surgery to avoid causing mechanical trauma to the recurrent laryngeal nerve which comes off the left vagus nerve, avoiding potential hoarseness as a permanent sequel after the surgical procedure. Vagus nerve stimulation Stimulus. The electrical stimulus was a combination of quasi-trapezoidal cathodic and rectangular anodic current pulses. Precisely, the resulting current, a biphasic and charge balanced combination was composed of a quasi-trapezoidal cathodic phase with a square leading edge with different intensity, a plateau of 300 s, and exponentially decaying phase of 500 s, followed by a wide rectangular anodic phase of a low current magnitude. Anodic phase was one-tenth of the magnitude in the cathodic phase. The width of the anodic phase was dependent upon the charge injected in the cathodic phase: the greater the charge, the wider the anodic phase. Identification of Particular Nerve Compartments and groups of tree electrodes. Stimuli with intensity of a quasi-trapezoidal cathodic phase of 2 mA with frequency of 20 Hz were delivered for 10 seconds quasi-bipolarly to all 13 GTEs within the cuff. Stimulation of separate GTE regions. The GTE that elicited the largest change in heart rate, namely GTE1, was considered as relevant for further stimulation.
Vagus stimulation with differing frequency and increasing current. 10-second long pulse trains with intensities of 0.5, 1.0, 1.5, 2.0 and 2.5 mA at different frequencies stimulation (10Hz, 20Hz and 30Hz) were delivered to the before mentioned GTE1 until the absence of cardiac contraction occurred. VNS was terminated instantly after the absence of cardiac contraction was noticed. The time interval between two different stimulations lasted until heart rate or systemic systolic arterial pressure had not reached basal values before stimulation train. At least five equal pulses were applied to analyze the effect on heart rate and arterial pressure. 
Data acquisition

Results
The first patient A 62 year old female, one month after anterior wall non-ST elevation myocardial infarction and a 15 year history of arterial hypertension, was the first patient included in our study. Two years before inclusion she had a percutaneous coronary intervention and stent implantation in the left coronary artery due to angina pectoris. Diagnostic evaluation showed important 3 vessel coronary artery disease and significant stenosis of the left internal carotid artery. Echocardiography showed mild left ventricular hypertrophy, normal left ventricular volume, mild systolic dysfunction and mild diastolic dysfunction. Valvular function was normal. She had mild, clinically unimportant pulmonary hypertension at rest. Her basal therapy was: carvedilol 6.25mg bid, perindopril 2 mg qd, trimetazidine MR 35mg bid, rosuvastatin 10mg qd, esomeprazole 40mg qd, alprazolam 0.25mg qd, aspirin 100mg qd. She was referred for endarterectomy of the left internal carotid artery and off-pump coronary artery by-pass graft surgery. Before starting VNS the patient was hemodynamically stable (heart rate 77 bpm, systemic arterial pressure 140/70 mmHg, pulmonary artery pressure 35/18 mmHg, central venous pressure 10 mmHg and pressure at airway opening 15mmHg). Changes of heart rate and systemic systolic arterial pressure during VNS are presented in figures 1. VNS at 10Hz provoked the most gradual decrease in the heart rate compared to 20 and 30 Hz VNS (p < 0.001). VNS at 10 Hz provoked the most gradual decrease of systolic arterial pressure compared to 20 and 30 Hz VNS (p < 0.001). Ventricular asystole was provoked by 2mA 20Hz VNS; atrio-ventricular block (2:1) was detected at 2mA with 30Hz VNS and at 2.5mA with 10Hz VNS. VNS was terminated immediately when ventricular asystole or atrio-ventricular block were detected. The heart rate increased instantaneously after termination of VNS. After the procedure, there was no clinically detectable recurrent laryngeal nerve injury. The second patient A 61 year old male was admitted due to unstable angina pectoris. His medical history was significant for arterial hypertension of 18 years. Diagnostic evaluation showed important 3 vessel coronary artery disease and significant stenosis of the left internal carotid artery. Echocardiography showed mild left ventricular hypertrophy, normal left ventricular volume, normal systolic function and mild diastolic dysfunction. Valvular function was normal. He had no pulmonary hypertension. His basal therapy was: carvedilol 3.125mg bid, atorvastatin 10 mg qd, aspirin 100mg qd. He was referred for endarterectomy of the left internal carotid artery and off-pump coronary artery by-pass graft surgery. Before beginning VNS the patient was hemodynamically stable (heart rate 67 bpm, systemic arterial pressure 135/68 mmHg, pulmonary artery pressure 25/16 mmHg, central venous pressure 8 mmHg and pressure at airway opening 15mmHg). Changes of heart rate and systemic systolic arterial pressure during VNS are presented in figures 2. VNS at 10 Hz provoked the most gradual decrease in heart rate compared to 20 and 30 Hz VNS (p < 0.05). VNS at 10 Hz provoked the most gradual decrease of systolic arterial pressure compared to 20 and 30 Hz VNS (p < 0.001). VNS provoked no devastating heart conduction abnormalities. After the procedure, there was no clinically detectable recurrent laryngeal nerve injury.
Discussion
In our human case study, the frequency and current dependant effects of selective VNS on heart rate and systemic systolic arterial pressure are reported. The most profound effects were detected when using 20Hz stimulation. On the other hand, 10Hz stimulation offers more gradual heart rate and systolic arterial pressure control and could clinically be more appropriate. Our work is based on previous studies which demonstrated that the human heart receives vagal postganglionic fibres from specific superficial compartments of the left vagus nerve and that these fibres are organized longitudinally along the length of the nerve. (15) It was shown that most of the fibers that comprise the human vagus nerve are small-diameter non-myelinated C-fibres; the rest are intermediate-diameter myelinated B-fibres and large-diameter myelinated A-fibres. (7) Most of the A-fibres, and many of the B-fibres, are given off in the cervical branches of the vagus nerve. A and B-fibres, are primarily cardiovascular and respiratory neurons. (16) (17) (18) (19) Different types of nerve fibres respond differently to various types of stimulating pulses. (8) (9) (10) (11) To stimulate mostly B-fibres, the combination of quasitrapezoidal cathodic and rectangular anodic current pulses, which we used in our study, was previously proposed. (20) It is assumed that propagation of action potential of A-fibres could be blocked by hyperpolarization at short-circuited anodes while activation of C-fibres could be abolished. To increase the parasympathetic stimulation of the heart, the number of fibres not blocked should be progressively increased by decreasing the magnitude of the current, applied by short-circuited anodes. As a result, the parasympathetic stimulation of the heart is progressively increased in a smaller-to-larger diameter fiber order, mimicking the body's natural method of increasing stimulation. Such stimulation enables the use of a cathodic current sufficiently weak to avoid stimulation of C fibres near the surface of the nerve, while still sufficiently strong to stimulate B fibres, including B fibres situated more deeply in specific compartments of the nerve. Stimulation of C-fibres is to be avoided because these fibres transmit pain sensations and are important for regulation of reflexes such as respiratory reflexes. Furthermore, by not stimulating A-fibres, adverse effects sometimes associated with dyspnea and hoarseness could be avoided. (21) Other side effects of non-selective vagus nerve stimulation are also described. (22) After our experimental protocol, no clinically important vagus nerve dysfunction was noticed. We used a special cuff design, as published previously. (14) Although cuffs are not entirely free from problems, their advantage is that the reproducibility of selective stimulations is superior. (23) Namely, the cuff can conform to the shape of the nerve, providing a low stimulation threshold by allowing a large stimulation contact area with the nerve. Furthermore, confinement of electric current within the cuff is maximized with the spiral design. Our human case study has at least 3 major limitations. First, only two patients were included and they were already on a beta blocking drug (carvedilol). Carvedilol could potentially influence our results. The first patient, in whom AV block and asystole were provoked, was on a higher dose of carvedilol than the second patient. Second, trains of stimuli were not ECG gated, so it is impossible to analyze the time from the beginning of the stimulus to the time of the effect. Third, in our report only acute effects were studied. It is not known how stimulation threshhold and stimulation efficiency could change with prolonged implantation. We have previously shown that in dogs prolonged implantation and stimulation through the same cuff design, as in the current study, were associated with a buildup of connective tissue encapsulation around the cuff as well as within the cuff. (24) It was also observed that there was some mechanical distortion of the nerve and neural damage. However, functional deficits were not observed. It can be concluded that selective VNS with trains of stimuli (combination of quasi-trapezoidal cathodic and rectangular anodic current pulses) produces frequency and current dependant effects on heart rate and systolic arterial pressure. The most profound effects are detected when using the 20Hz stimulation. However, the 10Hz stimulation offers more gradual heart rate and systemic systolic arterial pressure control and could be clinically more interesting. Selective VNS could in future be used for controlling heart rate during atrial fibrillation, heart failure, surgery and in critically ill patients.
